Las Vegas, NV -- (SBWIRE) -- 01/14/2013 -- Las Vegas, NV -- (SBWIRE) -- 01/14/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by http://beststocksdaily.com/
Epocrates, Inc.(NASDAQ:EPOC) is currently trading at $11.69, 0.13% higher. Epocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians.
Can EPOC Continues To Move Higher Back? Find Out Here http://beststocksdaily.com/p2/index.php?company=EPOC
LDK Solar Co., Ltd (ADR)(NYSE:LDK) is lower 4.19% to $2.06. LDK Solar Co., Ltd. is a vertically integrated manufacturer of Photovoltaic (PV) products. The Company’s products include Polysilicon, Solar Wafers, Solar Cells, Solar Modules and Solar Farm Projects. It operates in two segments: Polysilicon and Other PV products. Polysilicon segment involves the production and sales of polysilicon.
To Get complete technical analysis on LDK go to http://beststocksdaily.com/p2/index.php?company=LDK
ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD) added 7.98% to $5.41. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The Company has four product candidates in clinical development led by pimavanserin, which is in Phase III development as a first-in-class treatment for Parkinson's disease psychosis.
Get Free Trend Analysis on ACAD Here http://beststocksdaily.com/p2/index.php?company=ACAD
Celsion Corporation(NASDAQ:CLSN) among the gainers and the stock added 6.33% to $9.00. Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical trial for colorectal liver metastasis (CRLM) and a Phase II clinical trial for recurrent chest wall breast cancer.
To Get complete technical analysis on CLSN go to http://beststocksdaily.com/p2/index.php?company=CLSN
FuelCell Energy, Inc.(NASDAQ:FCEL) is lower 4.00% to $1.20. FuelCell Energy, Inc. (FuelCell Energy) is an integrated fuel cell company. FuelCell Energy designs, manufactures, sells, installs and services ultra-clean, stationary fuel cell power plants for distributed baseload power generation. The Company focuses to provide generation baseload power.
Get Free Trend Analysis on FCEL Here http://beststocksdaily.com/p2/index.php?company=FCEL
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)